Skip to main content
Clinical Trials/DRKS00027236
DRKS00027236
Recruiting
Phase 4

Immediate implant placement in molar extraction sockets using fully tapered tissue level implants: a randomized controlled post-market multinational clinical study - Immediate implant placement using fully tapered tissue level implants

Institut Straumann AG0 sites144 target enrollmentDecember 1, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Molar extraction site, immediate placement, delayed loading (loading protocol to be verified with principle investigators)
Sponsor
Institut Straumann AG
Enrollment
144
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients must have voluntarily signed the informed consent form before any study related procedures
  • \- Patients must be a minimum of 18 years of age
  • \- Periodontally healthy patients (no PPD greater than 4 mm except failing molar or PPD at implants higher than 6 mm)
  • \- Patients who are in need of a molar extraction (failing tooth) of the maxilla or mandible and replacement with a dental implant
  • \- Planned site for implant must have a natural tooth or implant mesially or distally in the adjacent tooth positions
  • \- Patients must have an opposing tooth (natural teeth or implant, fixed or removable restorations) to the planned site
  • \- Patients must be committed to the study and the required follow\-up visits

Exclusion Criteria

  • \- Patients with a systemic disease that would preclude dental implant surgery
  • \- Patients with any contraindications for oral surgical procedures
  • \- Patients with mucosal diseases (e.g., erosive lichen planus) in the localized area around the study implant site
  • \- Patients with a history of local irradiation therapy in the head/neck area
  • \- Patients with any untreated endodontic lesions or untreated periodontal disease adjacent to the implant site
  • \- Patients receiving, or having a history of receiving, intravenous or subcutaneous antiresorptive agents, such as bisphosphonates
  • \- Patients with inadequate oral hygiene (PI higher than 30%) or who are unmotivated for adequate oral hygiene
  • \- Patients who have physical or mental handicaps that would interfere with the ability to perform adequate oral hygiene
  • \- Patients who are pregnant or intending to become pregnant during the duration of the study
  • \- Patients who are heavy smokers (defined as \>10 cigarettes per day or \>1 cigar per day) or chew/dip tobacco

Outcomes

Primary Outcomes

Not specified

Similar Trials